Laboratory of Oral Microbiota and Systemic Diseases Shanghai Ninth People's HospitalCollege of StomatologyShanghai Jiao Tong University School of Medicine Shanghai China.
National Clinical Research Center for Oral Diseases Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology Shanghai China.
J Am Heart Assoc. 2020 Aug 4;9(15):e015862. doi: 10.1161/JAHA.120.015862. Epub 2020 Jul 28.
Background NCOR1 (nuclear receptor corepressor 1) is an essential coregulator of gene transcription. It has been shown that NCOR1 in macrophages plays important roles in metabolic regulation. However, the function of macrophage NCOR1 in response to myocardial infarction (MI) or vascular wire injury has not been elucidated. Methods and Results Here, using macrophage knockout mouse in combination with a mouse model of MI, we demonstrated that macrophage NCOR1 deficiency significantly reduced infarct size and improved cardiac function after MI. In addition, macrophage NCOR1 deficiency markedly inhibited neointimal hyperplasia and vascular remodeling in a mouse model of arterial wire injury. Inflammation and macrophage proliferation were substantially attenuated in hearts and arteries of macrophage knockout mice after MI and arterial wire injury, respectively. Cultured primary macrophages from macrophage knockout mice manifested lower expression of inflammatory genes upon stimulation by interleukin-1β, interleukin-6, or lipopolysaccharide, together with much less activation of inflammatory signaling cascades including signal transducer and activator of transcription 1 and nuclear factor-κB. Furthermore, macrophage knockout macrophages were much less proliferative in culture, with inhibited cell cycle progression compared with control cells. Conclusions Collectively, our data have demonstrated that NCOR1 is a critical regulator of macrophage inflammation and proliferation and that deficiency of NCOR1 in macrophages attenuates MI and neointimal hyperplasia. Therefore, macrophage NCOR1 may serve as a potential therapeutic target for MI and restenosis.
NCOR1(核受体共抑制因子 1)是基因转录的必需共调节因子。已经表明,巨噬细胞中的 NCOR1 在代谢调节中发挥重要作用。然而,巨噬细胞 NCOR1 在心肌梗死(MI)或血管丝损伤中的作用尚未阐明。
在这里,我们使用巨噬细胞敲除小鼠结合 MI 小鼠模型,证明巨噬细胞 NCOR1 缺乏显著减少 MI 后的梗死面积并改善心功能。此外,巨噬细胞 NCOR1 缺乏明显抑制动脉丝损伤小鼠模型中的新生内膜增生和血管重塑。MI 和动脉丝损伤后,巨噬细胞敲除小鼠的心脏和动脉中的炎症和巨噬细胞增殖明显减弱。从巨噬细胞敲除小鼠分离的原代巨噬细胞在受到白细胞介素 1β、白细胞介素 6 或脂多糖刺激时表现出较低的炎症基因表达,同时炎症信号级联包括转录激活因子 1 和核因子-κB 的激活也明显减少。此外,与对照细胞相比,巨噬细胞敲除细胞在培养中增殖较少,细胞周期进程受到抑制。
总之,我们的数据表明 NCOR1 是巨噬细胞炎症和增殖的关键调节因子,巨噬细胞中 NCOR1 的缺乏可减轻 MI 和新生内膜增生。因此,巨噬细胞 NCOR1 可能成为 MI 和再狭窄的潜在治疗靶点。